Health score, competitive moat, risk signals, and key metrics at a glance.
Competitive analysis based on 49 quarters of fundamental data
Operating margins are under pressure, averaging -0.2%. The business may lack pricing power or face rising costs.'
ROE is low or negative, suggesting limited competitive advantage or capital allocation challenges.
6 of the last 8 quarters generated positive FCF. The company generally funds itself but has occasional cash consumption quarters.
Revenue has been flat or declining over recent quarters, which may indicate eroding demand or competitive pressure.
Data-driven red flags and warnings across 49 quarters
Operating margins dropped 217.5% over recent quarters — a sharp decline suggesting serious cost or pricing challenges.
FCF consistently trails net income (avg -5.7x) — earnings may be inflated by non-cash items or aggressive accounting.
D/E ratio is 16.5 — dangerously high. The company is heavily leveraged and vulnerable to rising rates or cash flow dips.
TTM revenue has contracted 24.4% — significant decline indicating deteriorating demand.
FCF turned negative in 2 of the last 8 quarters — occasional cash consumption.
Shares decreased 14.4% — net buybacks are reducing shares outstanding and boosting per-share value.
as of March 2026
Revenue, EBITDA, operating income, net income, EPS, and shares
Gross, EBITDA, operating, and net margin trends
P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield
Total assets, cash, debt, book value, and leverage
Operating cash flow, free cash flow, FCF margin, and earnings quality
